Douglas J. Ringler

Health Technology

Consumer Services

Profile

Douglas J.
Ringler was the founder of LeukoSite, Inc. (founded in 1993) and Tolerx, Inc. (founded in 2000), where he held the title of Scientific Officer and President & Chief Executive Officer, respectively.
He also has an undergraduate and doctorate degree from the University of Pennsylvania.

Former positions of Douglas J. Ringler

Companies	Position	End
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Founder	19/12/2011
LeukoSite, Inc. LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.	Founder	01/01/1998

See the detail of Douglas J. Ringler's experience

Training of Douglas J. Ringler

University of Pennsylvania

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas J. Ringler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Health Technology
LeukoSite, Inc. LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.	Health Technology